Mad in America: Rethinking Mental Health

Carla Delgado is a San Diego native with eight years of experience in healthcare and a master's in healthcare administration. She also has a personal story of SSRI withdrawal, and we discuss how her background in healthcare administration helped to navigate the healthcare system, which has not been that friendly for people experiencing antidepressant withdrawal. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

Born in Germany and raised in Denmark, Fiona Frenzen is a qualified teacher with a master's degree in anthropology. For years, she had a dream about living in Iceland, seeking the grounding and healing effect of nature. But due to her health challenges and severe withdrawal syndrome, this dream seemed unrealistic. However, this past fall, she moved to a rural part of Iceland where she began teaching at the local elementary and high school. She dreams about putting her degree in anthropology to use by working in research and contributing to the awareness of the risks of antidepressants and the difficulties of withdrawal. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

Eric Jarvis is a Professor of Psychiatry at McGill University whose work brings attention to areas often overlooked in mainstream psychiatry, including religion, coercion, the social determinants of psychosis, and culture. He directs the Cultural Consultation Service, the First Episode Psychosis Program, and the Culture and Psychosis Working Group at the Jewish General Hospital, and is Editor-in-Chief of Transcultural Psychiatry. His research looks closely at how religious belief, spiritual practice, moral worlds, language, migration, racism, and social context shape how people experience distress, meaning, and healing. In this conversation, we explore how faith, culture, and power shape mental health practice. We discuss Jarvis's work on religion and spirituality in cultural psychiatry, his research on culture and the social causes of psychosis, and his studies of coercion in first-episode psychosis. We also talk about category fallacies, looping effects, and what happens when biomedical explanations of suffering collide with spiritual, familial, and community-based understandings of distress. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

Elizabeth Cotton is Associate Professor of Responsible Business at the University of Leicester and the founder of Surviving Work, which carries out socially engaged research on mental health and work. She has worked with health teams and trade unions, practiced as a psychotherapist in the NHS, and now runs the Digital Therapy Project, a group of UK and US researchers studying the future of therapy from both sides of the relationship. In her new book, UberTherapy: The New Business of Mental Health, she explores the effects of reorganizing mental health care around the logic of the app store. Therapy is now something you can scroll through on your phone, match with in seconds, and rate like a ride share. Platforms promise frictionless access and personalized care. What is harder to see is how this new "mental health marketplace" is reshaping what therapy is, how it feels, and who it is really built to serve. UberTherapy is part political economy, part insider account of therapy work, part literary exploration of what it actually feels like to bring our most distressed selves to the mental health app ecosystem. In the first part of our conversation, we discuss how Cotton's path through psychoanalysis, labor organizing, and sociology shaped Uber Therapy, and how shame and anger get intensified when platforms frame therapy as an easy consumer service. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

This week, we are joined by Chris Masterjohn, PhD. Chris is a nutritional scientist, a former professor, and the founder of Mitome. With a PhD in nutritional science and years of research in mitochondrial biology, Chris's work focuses on translating peer-reviewed science into practical tools for human health. At Mitome, Dr. Masterjohn pioneered the first analysis designed to measure mitochondrial respiratory chain function directly, identifying individual energy bottlenecks and guiding personalized science-backed protocols to optimize the system responsible for over 90% of cellular energy production. His mission is to bring mitochondrial testing out of the rare disease space and into everyday health. In this interview, we discuss why so little is understood about the role serotonin plays in the body and how our mitochondria might play a part in the experince of antidepressant withdrawal. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2025. Produced by James Moore https://www.jmaudio.org

In our first podcast of 2026, Robert Whitaker joins us to answer questions submitted by Mad in America readers and listeners. We discuss the validity of ADHD diagnoses, withdrawal and sexual dysfunction risks of SSRI antidepressants, the harms of electro-convulsive therapy (ECT), the rise of AI-generated misinformation and much more. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

Safa Askeri joins us to discuss his experience of antidepressant withdrawal and the gaslighting he was subjected to as he raised concerns with his doctors. "After this happened to me, I know that I can handle anything in life, no matter how hard it is." *** Like to know more about Mad in America or rethinking psychiatry more broadly? On our podcast, Robert Whitaker will answer your questions. Email questions to info@madinamerica.com by November 30, 2025 and we'll pick a selection for our December episode. We'd love to hear from you. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2025. Produced by James Moore https://www.jmaudio.org

On July 21st 2025, the FDA convened a hearing on maternal use of antidepressants during pregnancy and the impact this use has on fetal development. Around 400,000 children in the United States are born each year whose mothers took antidepressants while pregnant, and so it's easy to see the societal importance of this topic. What are the risks to the fetus, the newborn, and the long-term development of that child? Adam Urato and Joanna Moncrieff were members of that FDA panel, and so too were several others well-known to MIA readers, including David Healy and Joseph Witt-Doerring. The purpose of the panel was to assess whether the FDA needed to put a warning on antidepressants related to their use in pregnancy, and most on the panel spoke of research that told of the need to do so. However, after the panel concluded, the American Psychiatric Association and other medical associations, most notably the American College of Obstetricians and Gynecologists, responded with what can only be described as howls of outrage, issuing press releases and telling the public that the panel was biased and that the real risk during pregnancy was untreated mental illness. These medical organizations asserted that the increased risk of adverse outcomes for children born to depressed mothers is due to the illness and not the drug, and that there was plenty of evidence that antidepressants were a helpful and even life-saving treatment for maternal depression. Here is where we are today. That FDA hearing put two narratives on public display, and most media reports embraced the narrative put forth by the medical organizations. What we will do today is review the evidence that exists on this topic and the response by the medical guilds to a public airing of that evidence. Dr. Adam Urato is Chief of Maternal and Fetal Medicine at the Metro West Medical Center in Framingham, Massachusetts, and he has been speaking and writing about the risk of medications used during pregnancy for years. Dr. Joanna Moncrieff is a UK psychiatrist and researcher who was a co-founder of the Critical Psychiatry Network and is well known for her research on the safety and efficacy of psychiatric drugs. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2025. Produced by James Moore https://www.jmaudio.org